Please Wait
Applying Filters...

List of Tox21_300515 Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Menu
$ API Ref.Price (USD/KG) : 77Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AbbVie Inc

02 1DKSH

03 1Polfa Tarchomin

04 1Century Pharmaceuticals

05 1Tenatra Chemie

06 1Alembic Pharmaceuticals Limited

07 1Anhui Sinotech Industrial

08 1Anuh Pharma LTD

09 1Atom Pharma

10 1Calyx Chemicals & Pharmaceuticals Limited

11 1Cation Pharma

12 1Dalian Richon Chem

13 1Envee Drugs

14 1Halcyon Labs Private Limited

15 1Mehta API

16 1Mehta Pharmaceutical Industries

17 1SM BIOMED

18 1Unimax Group

19 1Zim Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AbbVie Inc

U.S.A
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly...

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company. Our ~30,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions. We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science.
Abbvie Company Banner

02

DKSH

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Erythromycin

About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...

DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
DKSH Company Banner

03

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Erythromycin

About the Company : Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related w...

Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.
Polfa Tarchomin

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCentury has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.

Erythromycin

About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...

Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in India and abroad. Its APIs are manufactured in accordance with cGMP, 21CFR part 10 and ICH guidelines. It also produces intermediates and develops new APIs as per the needs of its clients. Century conducts biotechnological research that focuses on human therapeutic proteins. Currently, research is underway to find treatments for asthma, mastocytosis and basophilic leukemia. Century supplies research-grade biotech products and a wide range of animal health products.
Century Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Erythromycin

About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...

Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opportunities grew, it was felt that the proprietorship firm had outlived its usefulness and that it needed a corporate structure. So, Tenatra Chemie Private Limited (TCPL) was incorporated in 2002. Since then, the company has come a long way, gaining valuable experience and knowledge in the fields of chemicals and pharmaceuticals in India.
Tenatra

06

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...

Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.
blank

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Anhui Sinotech Industrial Co.,Ltd is specially engaged in international marketing of food/feed additive,pesticides and chemicals. We are devoted ourselves to make the life better,a...

Anhui Sinotech Industrial Co.,Ltd is specially engaged in international marketing of food/feed additive,pesticides and chemicals. We are devoted ourselves to make the life better,always ready to provide top quality products combined with competitive price and comprehensive commercial service. By continuously efforts,the company has already established stable long-term business relationships with hundreds of oversea customers and domestic suppliers.Our products has exported to many countries and regions, including Southeast Asia,South America, Europe,etc.
blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Anuh Pharma Ltd belong to SK group based in India. We are leading manufacturers of API'S mainly Erythromycin Salts, Azithromycin, Clarithromycin, Roxithromycin, Pyrazinamide, Chlor...

Anuh Pharma Ltd belong to SK group based in India. We are leading manufacturers of API'S mainly Erythromycin Salts, Azithromycin, Clarithromycin, Roxithromycin, Pyrazinamide, Chloramphenicol and various Corticosteroids like Betamethasone Salts, Dexamethasone salts, Deflazacort, Mometasone Furoate, Prednisolone Sodium Phosphate. Manufacturing facility is located in Boisar 120 km from Mumbai, Our facility is GMP approved & inspected & approved by EDQM. We have CEP & EU GMP certificate for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide. WHO Geneva prequalifaction for Pyrazinamide. DMFS Available. We have state of art in house R&D facility located in Navi Mumbai & are open for Contract research opportunity.
blank

09

Atom Pharma

India
AAPS 2024
Not Confirmed
arrow

Atom Pharma

India
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Atom pharma is ISO 9001:2015 integrated, fastest growing and reputed Pharmaceutical bulk drugs [API] and pharmaceutical Intermediates exporting company. We have the industry’s br...

Atom pharma is ISO 9001:2015 integrated, fastest growing and reputed Pharmaceutical bulk drugs [API] and pharmaceutical Intermediates exporting company. We have the industry’s broadest portfolio of more than 80 high-quality API (active pharmaceutical ingredient) products, and more than 50 pharmaceutical intermediate. We offer the best APIs to our customers and have satisfied customers in over 20 countries. We ensure that our partners have the approved EUGMP, cGMP, USFDA, GMP, Halal-Kosher, and Korea FDA along with the documentation and systems that are required for a regulated market.
blank

10

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Deliver excellent quality through continuous research and development to satisfy customer needs on time, offer highest value to our customers through a Professional, integrated and...

Deliver excellent quality through continuous research and development to satisfy customer needs on time, offer highest value to our customers through a Professional, integrated and innovative business approach by constantly sensing customer’s needs.
blank

11

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Cation Pharma is a company that brings together the global availability of pharmaceutical raw material. Cation was founded in 2017, with an intention to be an active supplier of ...

Cation Pharma is a company that brings together the global availability of pharmaceutical raw material. Cation was founded in 2017, with an intention to be an active supplier of “Active Pharmaceutical Ingredient (API)” and their respective intermediates with a long range of chemicals. Manufacturing plant as per WHO-GMP guideline which itself shows our commitment to strict quality standards set by International Quality Agencie We have a High Value and Bulk Drugs product portfolio and continuously enhancing products in our portfolio, presenting ourselves as a source for diverse range of active pharmaceutical ingredients.
blank

12

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates ...

Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates and APIs. It has passed ISO9001:2000 international quality management system certificate. Its business scope includes development and manufacturing of APIs and pharmaceutical intermediates, contract development and manufacturing for domestic and international pharmaceutical companies, technical consultation, service and transfer.
blank

13

Envee Drugs

India
AAPS 2024
Not Confirmed
arrow

Envee Drugs

India
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : We take pride and pleasure to introduce “Envee Drugs Pvt. Ltd.” a leading manufacturer of Active Pharmaceutical Ingredients (APIs). Envee Drugs is a API manufacturer since 1998...

We take pride and pleasure to introduce “Envee Drugs Pvt. Ltd.” a leading manufacturer of Active Pharmaceutical Ingredients (APIs). Envee Drugs is a API manufacturer since 1998 situated in Gujarat, India a well-developed manufacturing hub housed with well-designed infrastructure for growth of Pharmaceutical Industry. Envee Drugs Pvt. Ltd. has a multipurpose manufacturing unit and currently producing “Macrolides, Corticosteroids along with few other commonly but essential Ingredients required by finished dosage manufacturers across globe.
blank

14

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : In recent years, India has become a destination for pharmaceutical research because of high intellectual capital and competitive technical costs. Indian professionals are exploring...

In recent years, India has become a destination for pharmaceutical research because of high intellectual capital and competitive technical costs. Indian professionals are exploring global avenues in pharmaceutical research with a fervour never felt before. (clinical pharmacology studies) We are people with 0% tolerance for unethical conduct and 100% belief in systems, processes and compliance for our corporate divisions. We are people with passion for success and the obsession to win. We have the potential growth catalysts with the zeal to achieve the impossible. We have set new benchmarks in the industry.
blank

15

Mehta API

India
AAPS 2024
Not Confirmed
arrow

Mehta API

India
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Mehta API Pvt Ltd engaged in manufacturing and marketing of APIs & Advance Drug Intermediates.... Globally. Mehta Api has been inordinately proud of its achievements since its ince...

Mehta API Pvt Ltd engaged in manufacturing and marketing of APIs & Advance Drug Intermediates.... Globally. Mehta Api has been inordinately proud of its achievements since its inception .Our journey is paved with many success stories. Much of it has, in many ways, been unprecedented in the Pharma industry. Our success has been validated by what we hold the dearest - Product Excellence and Customer service. We believe that long-term business success is rooted in value. Business ethics are good business; they are like a long-term insurance policy. We are committed to Excellence in Product Quality and adherence to stringent delivery schedule.
blank

16

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Mehta Pharmaceutical Industries engaged in Manufacturing and marketing of APls & Advance Drug Intermediates... Locally since 1970 and Globally since 1982. Primary Vendor to top Ind...

Mehta Pharmaceutical Industries engaged in Manufacturing and marketing of APls & Advance Drug Intermediates... Locally since 1970 and Globally since 1982. Primary Vendor to top Indian and Multinationals for a select range of their proprietary products - Proof of our commitment to Excellence in Product Quality and adherence to stringent delivery schedule.A technology driven company - setting up high benchmarks for Quality through adopting latest Technologies and Innovation. Export to about 12 countries across Asia, Africa and South America. we have achieved an annual sales of INR 700 million and have a work force of 65 peopIe.
blank

17

SM BIOMED

Malaysia
AAPS 2024
Not Confirmed
arrow

SM BIOMED

Malaysia
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Established in 1991, SM Biomed is a joint venture company pioneering the manufacture of API (active pharmaceutical ingredients) products in Malaysia. Company has grown several fold...

Established in 1991, SM Biomed is a joint venture company pioneering the manufacture of API (active pharmaceutical ingredients) products in Malaysia. Company has grown several folds as a market leader in the manufacture of macrolide antibiotics. Quality in the products & excellent service to our clients has been the essence of our success. Asia’s largest producer and exporter of Synthetic Macrolide antibiotics.Malaysia’s largest exporter of pharmaceuticals. We shall learn, we shall seek, attain higher peaks, soar and grow as a major force for the millennium.
blank

18

Unimax Group

India
AAPS 2024
Not Confirmed
arrow

Unimax Group

India
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Unimax is a leading Indian privately held company with global operations and is research driven with expertise in the development of APIs, and intermediates. We are engaged in the ...

Unimax is a leading Indian privately held company with global operations and is research driven with expertise in the development of APIs, and intermediates. We are engaged in the research, development, manufacturing, and distribution of high-quality pharmaceutical products and are a fully integrated company with in-house business development, R&D, manufacturing, and regulatory compliance capabilities.
blank

19

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Erythromycin

About the Company : Incepted in 1989, Zim has made a significant mark as a maverick pharma innovator. Throughout all these years constantly penetrating newer areas of pharmaceutical technology and bus...

Incepted in 1989, Zim has made a significant mark as a maverick pharma innovator. Throughout all these years constantly penetrating newer areas of pharmaceutical technology and business, Zim has established itself as one of the preferred healthcare solution provider in the field of new drug delivery systems. Headquartered in central India, in the industrial belt of Nagpur, we are a WHO GMP certified and ISO 9001:2008 accredited company supported by an excellent team of professionals and we have sufficient capacity to meet large requirements for different market segments. We are engaged in research and development, manufacturing, distribution and marketing of pharmaceutical dosage forms such as tablets, capsules, pellets, multi-particulate systems, dry syrups, directly compressible granules, taste masked powders, granules and orally disintegrating strips. At Zim we believe in constant innovation. We have earned appreciation for quality products and prompt services by domestic and international clients. Our business strategy is to innovate and deliver high-throughput technology based niche products. Zim is known in diverse, high-growth, niche markets, for institutional and pre-formulation intermediate businesses.
blank